Fate Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Fate Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fate Therapeutics Inc Strategy Report
- Understand Fate Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Fate Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
04 Jan 2021 | Fate Therapeutics Raises USD432 Million in Public Offering of Shares | Equity Offering | - |
Fate Therapeutics Inc |
14 Jul 2020 | Fate Therapeutics Enters into Licensing Agreement with Baylor College of Medicine | Licensing Agreement |
Fate Therapeutics Inc
|
Baylor College of Medicine
|
08 Jun 2020 | Fate Therapeutics Raises USD201.3 Million in Public Offering of Shares | Equity Offering | - |
Fate Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer